Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- BCTX
- Price
- 306.00
- Stock movement down
- -3.54 (-5.13%)
- Company name
- Briacell Therapeutics Corp
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 114.94M
- Ent value
- 122.64M
- Price/Sales
- 5070.01
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -50.69%
- 1 year return
- -92.80%
- 3 year return
- -81.41%
- 5 year return
- -64.26%
- 10 year return
- -
Last updated: 2025-09-12
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
BCTX does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 5070.01 |
| Price to Book | - |
| EV to Sales | 5409.43 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 1.76M |
| EPS (TTM) | -44.19 |
| FCF per share (TTM) | -223.31 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 22.67K |
| Gross profit (TTM) | 11.34K |
| Operating income (TTM) | -33.25M |
| Net income (TTM) | -4.85M |
| EPS (TTM) | -44.19 |
| EPS (1y forward) | -177.00 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 50.00% |
| Operating margin (TTM) | -146664.88% |
| Profit margin (TTM) | -21379.01% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 862.09K |
| Net receivables | 1.37M |
| Total current assets | 3.65M |
| Goodwill | 0.00 |
| Intangible assets | 199.80K |
| Property, plant and equipment | 456.80K |
| Total assets | 5.87M |
| Accounts payable | 7.17M |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 7.46M |
| Total liabilities | 8.56M |
| Shareholder's equity | -2.68M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -24.05M |
| Capital expenditures (TTM) | 449.64K |
| Free cash flow (TTM) | -24.50M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | -82.54% |
| Return on Invested Capital | 180.52% |
| Cash Return on Invested Capital | 912.37% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 68.72 |
| Daily high | 68.89 |
| Daily low | 63.49 |
| Daily Volume | 8K |
| All-time high | 917730.00 |
| 1y analyst estimate | 2350.00 |
| Beta | 1.41 |
| EPS (TTM) | -44.19 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| BCTX | S&P500 | |
| Current price drop from All-time high | -99.99% | -1.46% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 28 Jan 2025 | 9 Mar 2009 |
| Avg drop from high | -96.16% | -10.99% |
| Avg time to new high | 227 days | 12 days |
| Max time to new high | 2028 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
114.94M
Marketcap category
Small-cap
Description
BriaCell Therapeutics Corp., a clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted cell-based immunotherapy that is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer. The company is also developing Bria-OTS, a platform of personalized off-the-shelf cell-based immunotherapies, which is being evaluated in a Phase 1/2 clinical studies targeting breast cancer with extension to prostate cancer and other cancers. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.
Employees
0
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page